Evaluation of a single dose versus a divided dose regimen of amoxycillin in treatment of Actinobacillus pleuropneumoniae infection in pigs

Research in Veterinary Science

Volumn 79, Issue 1, 2005, Pages 61-67

  Lauritzen, B ^a,b   Lykkesfeldt, J ^a   Friis, C ^a  

^a UNIVERSITY OF COPENHAGEN   (Denmark)

^b NOVO NORDISK A S   (Denmark)

Author keywords

Actinobacillus pleuropneumoniae; Amoxycillin; Ascorbic acid; C reactive protein; Pigs; Zinc

Indexed keywords

AMOXICILLIN; ASCORBIC ACID; BIOCHEMICAL MARKER; C REACTIVE PROTEIN; CLAMOXYL VET; ZINC;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBIOTIC THERAPY; AREA UNDER THE CURVE; ARTICLE; BACTERIAL PNEUMONIA; BLOOD EXAMINATION; CLINICAL FEATURE; CLINICAL OBSERVATION; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DRUG ACTIVITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG MEGADOSE; EXPERIMENTAL INFECTION; GRAM NEGATIVE INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PROTEIN BLOOD LEVEL; QUANTITATIVE ANALYSIS; SWINE DISEASE; TIME; VITAMIN BLOOD LEVEL; ZINC BLOOD LEVEL;

ACTINOBACILLUS INFECTIONS; ACTINOBACILLUS PLEUROPNEUMONIAE; AMOXICILLIN; ANIMALS; ANTI-BACTERIAL AGENTS; AREA UNDER CURVE; DRUG ADMINISTRATION SCHEDULE; MALE; SWINE; SWINE DISEASES;

ACTINOBACILLUS PLEUROPNEUMONIAE; ANIMALIA; SUIDAE; TRIXIS;

EID: 18444379967     PISSN: 00345288     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.rvsc.2004.09.011     Document Type: Article

References (23)

1. H. Agersø C. Friis Bioavailability of amoxycillin in pigs Journal of Veterinary Pharmacology and Therapeutics 21 1998 41-46
2. H. Agersø C. Friis Penetration of amoxycillin into the respiratory tract tissues and secretion in pigs Research in Veterinary Science 64 1998 245-250
3. H. Agersø C. Friis J.P. Nielsen Penetration of amoxycillin to the respiratory tract tissues and secretions in Actinobacillus pleuropneumoniae infected pigs Research in Veterinary Science 64 1998 251-257
4. W.A. Craig Antimicrobial resistance issues of the future Diagnostic Microbiology and Infectious Disease 25 1996 213-217
5. W.A. Craig Pharmacokinetic/pharmacodynamic parameters: Rationale for antibacterial dosing of mice and men Clinical Infectious Diseases 26 1998 1-12
6. W.A. Craig D. Andes Pharmacokinetics and pharmacodynamics of antibiotics in otitis media Pediatric Infectious Disease Journal 15 1996 255-259
7. W.A. Craig S.C. Ebert Killing and regrowth of bacteria in vitro: A review Scandinavian Journal of Infectious Diseases 74 Suppl. 1991 63-70
8. P. Dom F. Haesebrouck R. Ducatelle G. Charlier In vivo association of Actinobacillus pleuropneumoniae serotype 2 with the respiratory epithelium of pigs Infection and Immunity 64 1994 1262-1267
9. S.C. Ebert W.A. Craig Pharmacodynamic properties of antibiotics: application to drug monitoring and dosage regimen design Infection Control and Hospital Epidemiology 11 1990 319-326
10. N. Frimodt-Møller M.W. Bentzon W.F. Thomsen Experimental infection with Streptococcus pneumoniae in mice: Correlation of in vitro activity and pharmcokinetic parameters with in vivo effect for 14 cephalosporins Journal of Infectious Diseases 154 1986 511-517
11. S. Giese E. Stenbæk R. Nielsen Identification of Actinobacillus pleuropneumoniae serotype 2 by monoclonal or polyclonal antibodies in latex agglutination test Acta Veterinaria Scandinavica 34 1993 223-225
12. P.M.H. Heegaard J. Klausen J.P. Nielsen N. González-Ramón M. Piñeiro F. Lampreave M.A. Alava The porcine acute phase response to infection with Actinobaccillus pleuropneumoniae. Haptoglobin, C-reactive protein, major acute phase protein and serum amyloid A are sensitive indicators of infection Comparative Biochemistry and Physiology. Series B. Biochemistry and Molecular Biology 2 1998 365-373
13. J.D. Knudsen N. Frimodt-Møller F. Espersen Experimental Streptococcus pneumoniae infection in mice for studying correlation of in vitro and in vivo activities of penicillin against Pneumococci with various susceptibilities to penicillin Antimicrobial Agents and Chemotherapy 39 1995 1253-1258
14. G.D. Koritz R.F. Bevill Role of pharmacokinetics in the outcome of treatment of infections Acta Veterinaria Scandinavica 87 Suppl. 1991 18-27
15. B. Lauritzen J. Lykkesfeldt C. Friis Evaluation of a single dose versus a divided dose regimen of danofloxacin in treatment of Actinobacillus pleuropneumoniae infection in pigs Research in Veterinary Science 74 2003 271-277
16. B. Lauritzen J. Lykkesfeldt M.T. Skaanild Ø. Angen J.P. Nielsen C. Friis Putative biomarkers for evaluation of antibiotic treatment: An experimental model of porcine Actinobacillus pleuropneumoniae infection Research in Veterinary Science 74 2003 261-270
17. R.H. Lindecrona C. Friis F.M. Aarestrup The pharmacodynamic effect of amoxycillin and danofloxacin against Salmonella Typhimurium in an in vitro pharmacodynamic model Research in Veterinary Science 68 2000 261-264
18. R.H. Lindecrona C. Friis N.E. Jensen The pharmacodynamic effect of amoxycillin and danofloxacin against Actinobacillus pleuropneumoniae in an in vitro pharmacodynamic model Research in Veterinary Science 67 1999 93-97
19. J. Lykkesfeldt Determination of ascorbic acid and dehydroascorbic acid in biological samples by high-performance liquid chromatography using subtraction methods: Reliable reduction with tris[2-carboxyethyl]phosphine hydrochloride Analytical Biochemistry 282 2000 89-93
20. C.D. Marchant S.A. Carlin C.E. Johnson P.A. Shurin Measuring the comparative efficacy of antibacterial agents for acute otitis media: The "Pollyanna phenomenon" Journal of Pediatrics 120 1992 72-77
21. D.J. Taylor Actinobacillus pleuropneumoniae In: B.E. Straw S. D'Allaire W.L. Mengeling D.J. Taylor (Eds.) Diseases of Swine eighth ed 1999 Iowa State University Press Ames, IA, USA 343-354
22. P.L. Toutain J.R. Del castillo A. Bousquet-Melou The pharmacokinetic-pharmacodynamic approach to a rational dosage regimen for antibiotics Research in Veterinary Science 73 2002 105-114
23. B. Vogelman S. Gudmundson J. Leggett J. Turnidge S. Ebert W.A. Craig Correlation of antimicrobial pharmacokinetic parameters with therapeutic efficacy in an animal model Journal of Infectious Diseases 158 1988 831-847